Mindray continues scouting for M&A with strong cash position; COVID-19 enhances global customers – IR

Date: May 2020
China’s largest medical equipment manufacturer Shenzhen Mindray Bio-Medical Electronics [SHE: 300760], will be actively scouting for M&A targets throughout the next three to five years with its strong cash reserves at hand, the company’s IR official told Mergermarket.
The information on this page may have been provided by a contributor to ChinaGoAbroad, and ChinaGoAbroad makes no guarantees about the accuracy of any content. All content shall be used for informational purposes only. Contributors must obtain all necessary licenses and/or ownership rights from the relevant content owner(s) before submitting such content (including texts, pictures, photos and diagrams) to ChinaGoAbroad for publication. ChinaGoAbroad disclaims all liability arising from the publication of any content/information (such as texts, pictures, photos and diagrams that infringe on any copyright) received from contributors. Links may direct to third party sites out of the control of ChinaGoAbroad, and such links shall not be considered an endorsement by ChinaGoAbroad of any information contained on such third party sites. Please refer to our Disclaimer for more details.